BRPI0812013A2 - formulações para administração oral de agentes terapêuticos e métodos relacionaods. - Google Patents

formulações para administração oral de agentes terapêuticos e métodos relacionaods.

Info

Publication number
BRPI0812013A2
BRPI0812013A2 BRPI0812013A BRPI0812013A BRPI0812013A2 BR PI0812013 A2 BRPI0812013 A2 BR PI0812013A2 BR PI0812013 A BRPI0812013 A BR PI0812013A BR PI0812013 A BRPI0812013 A BR PI0812013A BR PI0812013 A2 BRPI0812013 A2 BR PI0812013A2
Authority
BR
Brazil
Prior art keywords
formulations
oral administration
therapeutic agents
related methods
methods
Prior art date
Application number
BRPI0812013A
Other languages
English (en)
Inventor
K Wasan Ellen
M Wasan Kishor
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia filed Critical Univ British Columbia
Priority claimed from PCT/CA2008/000975 external-priority patent/WO2008144888A1/en
Publication of BRPI0812013A2 publication Critical patent/BRPI0812013A2/pt
Publication of BRPI0812013A8 publication Critical patent/BRPI0812013A8/pt
Publication of BRPI0812013B1 publication Critical patent/BRPI0812013B1/pt

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
BRPI0812013-7A 2007-05-25 2008-05-23 Formulações para a administração oral de agentes terapêuticos e métodos relacionados BRPI0812013B1 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US64030707P 2007-05-25 2007-05-25
US60/640,307 2007-05-25
US97670807P 2007-10-01 2007-10-01
US60/976,708 2007-10-01
US4147808P 2008-04-01 2008-04-01
US61/041,478 2008-04-01
PCT/CA2008/000975 WO2008144888A1 (en) 2007-05-25 2008-05-23 Formulations for the oral administration of therapeutic agents and related methods

Publications (3)

Publication Number Publication Date
BRPI0812013A2 true BRPI0812013A2 (pt) 2017-03-21
BRPI0812013A8 BRPI0812013A8 (pt) 2018-02-06
BRPI0812013B1 BRPI0812013B1 (pt) 2022-03-22

Family

ID=58343413

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0812013-7A BRPI0812013B1 (pt) 2007-05-25 2008-05-23 Formulações para a administração oral de agentes terapêuticos e métodos relacionados

Country Status (1)

Country Link
BR (1) BRPI0812013B1 (pt)

Also Published As

Publication number Publication date
BRPI0812013A8 (pt) 2018-02-06
BRPI0812013B1 (pt) 2022-03-22

Similar Documents

Publication Publication Date Title
BRPI0908292A2 (pt) "métodos e composições para administração oral de exenatida"
BRPI0817075A2 (pt) núcleos de fármaco para liberação prolongada de agentes terapêuticos
DK2328601T3 (da) Linaclotid-holdige formuleringer til oral indgivelse
BRPI0812562A2 (pt) composições terapêuticas anti-cd20 e métodos
BRPI0820381A2 (pt) Formulações farmacêuticas
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BRPI0819218A2 (pt) Métodos, estojos e composições para administração de compostos farmacêuticos
DK2114531T3 (da) Punktpropper og fremgangsmåder til indgivelse af terapeutiske midler
DK2692341T3 (da) Misbrugs-resistent lægemiddelformulering
HK1142823A1 (en) Formulations for the oral administration of therapeutic agents and related methods
BRPI0907077A2 (pt) métodos e composições para administração oral de proteínas
BRPI0807544A2 (pt) Sólido farmacêutico e dose de vacina
BRPI0913379A2 (pt) formulações farmacêuticas sólidas compreendendo bibw 2992
BRPI0720100A2 (pt) Implemento para cuidado oral
BRPI0917444A2 (pt) composições farmacêuticas de retenção gástrica para o tratamento e prevenção de doenas do snc
BRPI0822885A2 (pt) Implemento para cuidado oral, método para administrar um agente ativo, e, kit para cuidado oral
BRPI0821732A2 (pt) Formulações de liberação controlada , forma de dosagem sólida, e, uso da formulação de liberação controlada
DK2049525T3 (da) N-laminoheteroaryl)-1H-indol-2-carboxamid-derivater, og fremstilling og terapeutisk anvendelse deraf
BRPI0916877A2 (pt) composição farmacêutica e administração da mesma
EP1838291A4 (en) PHARMACEUTICAL FORMULATIONS AND METHOD OF USE THEREOF
ZA200808114B (en) Formulations of low dose non-steroidal anti-inflammatory drugs and betacyclodextrin
BRPI0719394A2 (pt) Preparação medicinal sólida
CY2018006I2 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
BR112012003280A2 (pt) composição farmacêutica para administração oral, método para tratar uma doença, uso do composto, e, composto.
BRPI1007484A2 (pt) composição farmacêutica para administração oral

Legal Events

Date Code Title Description
B08E Application fees: payment of additional fee required [chapter 8.5 patent gazette]
B08G Application fees: restoration [chapter 8.7 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/05/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.